-

Owens & Minor to Present at the 29th Annual Credit Suisse Healthcare Conference

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today that the company will participate in the 29th Annual Credit Suisse Healthcare Conference on November 12, 2020.

Ed Pesicka, President and CEO, of Owens & Minor, will participate in a fireside chat with analysts and investors at the conference. The discussion, which will begin at approximately 10:15 AM ET on November 12, 2020, will be webcast live and may be accessed at www.owens-minor.com under the Investor Relations section. The webcast will be archived and available for replay on the website for 30 days.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. With over 15,000 dedicated teammates serving healthcare industry customers in 70 countries, Owens & Minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. A FORTUNE 500 company, Owens & Minor was founded in 1882 in Richmond, Virginia, where it remains headquartered today. The Company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter, and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

Contacts

Chandrika Nigam, Director, Investor Relations, Investor.Relations@owens-minor.com, 833-621-7812

Industry:

Owens & Minor

NYSE:OMI
Release Summary
Owens & Minor to Present at the 29th Annual Credit Suisse Healthcare Conference
Release Versions
English
Hashtags
#creditsuissehealthcareconference
#fortune500
#healthcare
#healthcareconference

Contacts

Chandrika Nigam, Director, Investor Relations, Investor.Relations@owens-minor.com, 833-621-7812

Social Media Profiles
Owens & Minor
Owen & Minor
More News From Owens & Minor

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously...

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917....

Accendra Health Reports Fourth Quarter 2025 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are...
Back to Newsroom